Professor of Clinical Pharmacy
University of California, San Francisco, California
Conan MacDougall, PharmD, MAS, BCPS, BCIDP is Associate Dean for Integrated Core Curriculum, Co-Vice Dean for PharmD Education, and Professor of Clinical Pharmacy in the Department of Clinical Pharmacy at the University of California, San Francisco. Dr. MacDougall teaches pharmacy, medical, and nursing trainees at UCSF, for which he has twice received the Academic Senate Campus Award for Distinction in Teaching. A member of the School of Medicine’s Academy of Medical Educators, he has been recognized as an Emerging Teaching Scholar by the American Association of Colleges of Pharmacy and received the Albert B. Prescott Pharmacy Leadership Award from the Pharmacy Leadership & Education Institute.
Dr. MacDougall provides clinical service to the Infectious Diseases Consult Service at UCSF Medical Center. His research interests include approaches for interactive learning around appropriate antimicrobial use and the pharmacoepidemiology of antimicrobial use in hospitals. He is co-author of Antibiotics Simplified, Antimicrobial Section Editor for Goodman & Gilman’s The Pharmacological Basis of Therapeutics, and a chapter author in Principles and Practice of Infectious Diseases, Poisoning and Drug Overdose, and Emergency Management of Infectious Diseases.
Dr. MacDougall's original research and reviews have been published in Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Microbiology Reviews, Emerging Infectious Diseases, Archives of Internal Medicine, American Journal of Pharmaceutical Education, and Pharmacotherapy. He currently serves as Chair of the Specialty Council on Infectious Diseases for the Board of Pharmaceutical Specialties and is an active member of the Medical Education Community of Practice of the Infectious Diseases Society of America.
Disclosure information not submitted.
Saturday, July 20, 2024
10:30 AM – 11:15 AM East Coast USA Time
Software as a Drug: Revolutionizing Patient Care With Digital Therapeutics
Sunday, July 21, 2024
3:30 PM – 4:00 PM East Coast USA Time